Renal involvement in autoimmune connective tissue diseases
نویسندگان
چکیده
منابع مشابه
Renal involvement in autoimmune connective tissue diseases
Connective tissue diseases (CTDs) are a heterogeneous group of disorders that share certain clinical presentations and a disturbed immunoregulation, leading to autoantibody production. Subclinical or overt renal manifestations are frequently observed and complicate the clinical course of CTDs. Alterations of kidney function in Sjögren syndrome, systemic scleroderma (SSc), auto-immune myopathies...
متن کاملNeutrophilic Skin Lesions in Autoimmune Connective Tissue Diseases
The pathophysiology of neutrophilic dermatoses (NDs) and autoimmune connective tissue diseases (AICTDs) is incompletely understood. The association between NDs and AICTDs is rare; recently, however, a distinctive subset of cutaneous lupus erythematosus (LE, the prototypical AICTD) with neutrophilic histological features has been proposed to be included in the spectrum of lupus. The aim of our s...
متن کاملLung Involvement in Undifferentiated Connective Tissue Diseases: A Rheumatology Perspective
Objectives: Studies pointing out the occurrence of Interstitial Lung Diseases (ILD) in Undifferentiated Connective Tissue Diseases (UCTD) have been so far derived from patients admitted to Respiratory Medicine Units. We undertook the present prospective study to investigate for the presence of lung involvement, patients admitted to a Rheumatology Unit and diagnosed as UCTD. Materials and Method...
متن کاملEndothelin in human autoimmune diseases with renal involvement.
Endothelin (ET)-1 is a potent renal vasoconstrictor with pro-inflammatory, profibrotic and mitogenic potential. Animal studies support a pathogenetic contribution of ET-1 and its cognate receptors in several renal manifestations of autoimmune disorders. However, data in humans are limited. The present minireview thus summarizes the observations available in humans. Similar to animal models, ET-...
متن کاملAutoimmune and connective tissue disorders
Pregnant women with autoimmune rheumatic diseases, especially systemic lupus erythematosus (SLE) and systemic sclerosis, are at high risk of maternal disease flares, adverse fetal outcomes and potential drug teratogenic effects, making the management of these women particularly challenging. With improvements in diagnosis and treatment, however, these risks can be minimized by appropriate timing...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMC Medicine
سال: 2013
ISSN: 1741-7015
DOI: 10.1186/1741-7015-11-95